Shashwati Basak - Concepedia

Author

Shashwati Basak

Stanford University

Also Known As

Shashwati Basak

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Stanford University University of California, San Francisco University of Southern California UCSF Helen Diller Family Comprehensive Cancer Center Biocon (India)

About

Shashwati Basak is an author at Stanford University specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	768
2	Cell Biology	4	4	707
3	Pharmacology	3	3	106
4	Biochemistry	1	1	45
5	Pathology	1	1	21

Shashwati Basak

Publications

Citations

H-Index

Page 1

	Year	Citations
Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression Colleen A. Brady, Dadi Jiang, Stephano S. Mello, Cell Tumor BiologyGenome InstabilityMedicineTumor SuppressionCell Death	2011	530
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells Emily J. Noonan, Robert F. Place, Shashwati Basak, Oncotarget	2010	142
Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function Shashwati Basak, Deepa Pookot, Emily J. Noonan, Molecular Cancer Therapeutics	2008	127
The Metastasis-Associated Gene Prl-3 Is a p53 Target Involved in Cell-Cycle Regulation Shashwati Basak, Suzanne B.R. Jacobs, Adam J. Krieg, Molecular Cell Metastasis-associated Gene Prl-3Tumor BiologyP53 Target InvolvedCell RegulationMedicine	2008	118
Toxic and Chemopreventive Ligands Preferentially Activate Distinct Aryl Hydrocarbon Receptor Pathways: Implications for Cancer Prevention Steven T. Okino, Deepa Pookot, Shashwati Basak, Cancer Prevention Research Chemoprevention StrategyAhr LigandsToxicological MechanismAnti-cancer AgentAhr Ligand	2009	45
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours Kyaw Aung, Anthony B. El-Khoueiry, Karen A. Gelmon, Investigational New Drugs Multi-arm PhaseOncologyMedicineAdvanced Solid TumoursPharmacotherapy	2018	40
A phase I study of AL101, a pan-NOTCH inhibitor, in patients (pts) with locally advanced or metastatic solid tumors. Anthony B. El-Khoueiry, Jayesh Desai, Swaminathan P. Iyer, Journal of Clinical Oncology Notch ActivityMedicinePan-notch InhibitorPharmacologyNotch Receptors	2018	21
Transcriptional activator C protein-mediated unwinding of DNA as a possible mechanism for mom gene activation Shashwati Basak, Valakunja Nagaraja Journal of Molecular Biology ChromatinTranscriptional RegulationMom Gene ActivationGeneticsTranscription Regulation	1998	14

Page 1